The vaping cessation pill, varenicline, is emerging as a game-changer in the fight against nicotine addiction, especially among teens and young adults.In a groundbreaking study conducted by Mass General Brigham, participants who took this FDA-approved smoking cessation pill were found to be more than three times as likely to quit vaping compared to those relying on behavioral support alone.